Cue Health Inc.

Equities

HLTH

US2297901009

Software

Market Closed - Nasdaq 04:00:00 2024-04-19 pm EDT 5-day change 1st Jan Change
0.1451 USD +2.18% Intraday chart for Cue Health Inc. -10.76% -10.71%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Cue Health Inc. Receives Response Letter from the U.S. Food and Drug Administration Regarding Its De Novo Request CI
Cue Health Inc. Announces Executive Changes CI
Cue Health Inc. Announces Chief Executive Officer Changes CI
North American Morning Briefing : Inflation -2- DJ
BTIG Downgrades Cue Health to Neutral From Buy MT
Transcript : Cue Health Inc., Q4 2023 Earnings Call, Mar 13, 2024
Earnings Flash (HLTH) CUE HEALTH Posts Q4 Revenue $18.8M, vs. Street Est of $17.7M MT
Cue Health Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Cue Health Inc. Reports Impairment of Long-Lived Assets for the Fourth Quarter Ended December 31, 2023 CI
Cue Health Inc. Provides Revenue Guidance for the First Quarter of 2024 CI
Cue Health Enters into Cooperation Agreement with Tarsadia Investments CI
Cue Health Appoints Rishi Reddy to Board of Directors CI
Wall Street Set to Open 2024 Lower Amid Rise in Oil Prices, Ahead of Manufacturing, Construction Data MT
US Equity Futures Set Kick Off 2024 Lower Ahead of Manufacturing PMI, Construction Data MT
Cue Health Inc.(NasdaqCM:HLTH) dropped from NASDAQ Biotechnology Index CI
Goldman Sachs Trims Price Target on Cue Health to $0.50 From $0.75, Maintains Neutral Rating MT
Cue Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Transcript : Cue Health Inc., Q3 2023 Earnings Call, Nov 08, 2023
Earnings Flash (HLTH) CUE HEALTH Reports Q3 Revenue $17.5M, vs. Street Est of $11.2M MT
Cue Health Inc. Provides Revenue Guidance for the Fourth Quarter of 2023 CI
Kelly Day Sends Letter to the Board of Directors of Cue Health CI
Cue Health Inc. Declares Dividend Distribution CI
Cue Health Inc.(NasdaqGS:HLTH) dropped from S&P Global BMI Index CI
Transcript : Cue Health Inc. Presents at Morgan Stanley 21st Annual Global Healthcare Conference 2023, Sep-11-2023 02:55 PM
Cue Health Shareholder Tarsadia Seeks Strategic Review, Shareholder Representation on Board MT
Chart Cue Health Inc.
More charts
Cue Health Inc. is a healthcare technology company. The Company is engaged in providing individuals with a connected diagnostic platform that bridges the physical and virtual care continuum. Its platform, Cue Integrated Care Platform, which consists of hardware, software and diagnostic components: the Cue Health Monitoring System, which is made up of a portable, durable and reusable reader, or Cue Reader, a single-use test cartridge, or Cue Cartridge, and a sample collection wand, or Cue Wand; Cue Data and Innovation Layer, with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, including its app and Cue Enterprise Dashboard, and its Cue Ecosystem Integrations and apps, which allow for integrations with third party applications and sensors. Its products include Cue Reader, COVID-19 Test, Cue Test Kits, Cue Care, and Cue+ Membership. It offers solutions for home/personal, business, public sector, healthcare, retail pharmacies, entertainment and education sectors.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
0.142 USD
Average target price
0.75 USD
Spread / Average Target
+428.17%
Consensus
  1. Stock Market
  2. Equities
  3. HLTH Stock
  4. News Cue Health Inc.
  5. Cue Health to Provide Monitoring System, COVID-19 Test to Fresenius Kidney Care